UAS regulatory sequences drive expression of Hsap\ATXN2 with an expanded polyQ repeat (32Q).
Hsap\ATXN232Q.UAS, Scer\GAL4GMR.PU is an enhancer of visible phenotype of Hsap\TARDBPUAS.cEa, Scer\GAL4GMR.PU
Hsap\ATXN232Q.UAS, Scer\GAL4elav.PLu is an enhancer of short lived phenotype of Hsap\TARDBPUAS.cEa, Scer\GAL4elav.PLu
Hsap\ATXN232Q.UAS, Scer\GAL4elav.Switch.PO is an enhancer of abnormal locomotor behavior | adult stage | RU486 conditional phenotype of Hsap\TARDBPUAS.cEa, Scer\GAL4elav.Switch.PO
Hsap\ATXN232Q.UAS, Scer\GAL4GMR.PU, pAbpUAS.cSa has visible phenotype
Hsap\ATXN232Q.UAS, Scer\GAL4GMR.PU is an enhancer of eye phenotype of Hsap\TARDBPUAS.cEa, Scer\GAL4GMR.PU
Hsap\ATXN232Q.UAS, Scer\GAL4GMR.PU, pAbpUAS.cSa has eye phenotype
he reduction in lifespan induced by the expression of Hsap\TARDBPScer\UAS.cEa (under the control of Scer\GAL4elav.PLu) and climbing defects (under the control of Scer\GAL4elav.Switch.PO and raised with RU486) are also not enhanced.
Co-expression of pAbpScer\UAS.cSa and Hsap\ATXN232Q.ΔPAM2.Scer\UAS.T:Hsap\MYC under the control of Scer\GAL4GMR.PU does not induce retinal degeneration.